title: Intravitreal ranibizumab for choroidal neovascularization associated with circumscribed choroidal haemangioma.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Querques
authors.forename: Raimondo
authors.initials: R
authors.lastname: Forte
authors.forename: Lea
authors.initials: L
authors.lastname: Querques
authors.forename: Eric H
authors.initials: EH
authors.lastname: Souied
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D002830:Choroid Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D005451:Fluorescein Angiography; D006391:Hemangioma / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000175:diagnosis; D000069579:Ranibizumab; D019233:Retreatment; D041623:Tomography, Optical Coherence; D014792:Visual Acuity / Q000502:physiology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab